DRD2 and familial pancreatic carcinoma: High DRD2 expression by tumour cells was most frequently observed in pheochromocytomas (30 out of 63 samples), ovarian cancer (6 out of 12 samples) and pancreatic cancer (6 out of 12 samples) (Fig. 1).